Trial intelligence / Profile preview

Ayahuasca Effects on Cerebral Metabolism in Healthy Volunteers

NCT07893912Phase 1Enrolling by invitation

Sponsor
Universidade de São Paulo
Start
Oct 2026
Primary completion
Dec 2027
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of ayahuasca, sponsored by Universidade de São Paulo. Primary endpoint: Regional cerebral glucose metabolic rate at 4 hours. Started Oct 2026; status: enrolling by invitation.

02

Drugs

ayahuasca

Beyond the preview

Go deeper on NCT07893912.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07893912.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call